查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物样本库市场报告：2030 年趋势、预测与竞争分析
市场调查报告书
商品编码
1356780

生物样本库市场报告：2030 年趋势、预测与竞争分析

Biobanking Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

生物样本库趋势与预测

预计到 2030 年，全球生物银行市场将达到 61 亿美元，2024 年至 2030 年年复合成长率为 10.5%。该市场的主要驱动力是基因检测和精准医疗需求的不断增长、新生儿脐带血干细胞储存的日益普及以及虚拟生物库软体的出现。全球生物样本库市场的未来充满希望，为製药和生物技术公司、CRO、学术和研究机构以及医院市场提供了机会。

生物样本库市场洞察

Lucintel 预测，在预测期内，设备将经历最高的成长。

预计亚太地区在预测期内将出现最高成长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球生物样本库市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球生物样本库市场趋势（2018-2023）与预测（2024-2030）
  • 按样本类型分類的全球生物样本库市场
    • 血液製品
    • 人体组织
    • 细胞株
    • 核酸
    • 体液
    • 人类排泄物
  • 按产品和服务分類的全球生物样本库市场
    • 装置
    • 消耗品
    • 服务
    • 软体
  • 按应用分類的全球生物样本库市场
    • 再生医学
    • 生命科学研究
    • 临床调查
  • 按最终用途分類的全球生物样本库市场
    • 製药和生物技术公司以及 CRO
    • 学术研究所
    • 医院

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球生物样本库市场
  • 北美生物样本库市场
  • 欧洲生物样本库市场
  • 亚太生物样本库市场
  • 其他区域生物样本库市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按样本类型分類的全球生物样本库市场成长机会
    • 按产品和服务分類的全球生物样本库市场成长机会
    • 按应用分類的全球生物样本库市场成长机会
    • 按最终用途分類的全球生物样本库市场成长机会
    • 按地区分類的全球生物样本库市场成长机会
  • 全球生物样本库市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球生物样本库市场的容量
    • 全球生物银行市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Thermo Fisher Scientific
  • PHC Holdings
  • Becton
  • Dickinson and Company
  • QIAGEN NV
  • Merck KGaA
  • Avantor
  • Cryoport
  • Tecan Trading
  • Azenta
简介目录

Biobanking Trends and Forecast

The future of the global biobanking market looks promising with opportunities in the therapeutics, drug discovery & clinical research, clinical diagnostics, and other markets. The global biobanking market is expected to reach an estimated $xxx billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are significant capital allocation to the research and development of cutting-edge therapies, including regenerative medicine, personalized medicine and in-depth studies on cancer genomics and high incidence of chronic diseases.

A more than 150-page report is developed to help in your business decisions.

Biobanking by Segment

The study includes a forecast for the global biobanking by product & service, sample type, application, end use industry, and region.

Biobanking Market by Product & Service [Shipment Analysis by Value from 2018 to 2030]:

  • Equipment
  • Consumables
  • Software
  • Services

Biobanking Market by Sample Type [Shipment Analysis by Value from 2018 to 2030]:

  • Blood
  • Tissue
  • Nucleic Acids
  • Cell Lines

Biobanking Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutics
  • Drug Discovery & Clinical Research
  • Clinical Diagnostics
  • Other Applications

Biobanking Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies and Cros
  • Academic & Research Institutes
  • Hospitals

Biobanking Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biobanking Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biobanking companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biobanking companies profiled in this report include-

  • Thermo Fisher Scientific
  • PHC Holdings
  • Becton
  • Dickinson and Company
  • Qiagen
  • Greiner Holding
  • Bay Biosciences

Biobanking Market Insights

Lucintel forecasts that equipment is expected to witness highest growth over the forecast period due to due to need of wide range of specialized equipments and products essential for the processing, analysis, storage, and transport of biological samples.

Within this market, therapeutics will remain the largest segment due to the growing demand for advanced therapies for the treatment of chronic diseases.

North America is expected to witness highest growth over the forecast perioddue to growing government efforts, including funding and the advancement of the biobanks market in the united states.

Features of the Global Biobanking Market

Market Size Estimates: Biobanking market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biobanking market size by various segments, such as by product & service, sample type , application, end use industry, and region in terms of ($B).

Regional Analysis: Biobanking market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & service, sample types , applications, end use industries, and regions for the biobanking market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biobanking market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the biobanking market size?

Answer: The global biobanking market is expected to reach an estimated $xxx billion by 2030.

Q.2 What is the growth forecast for biobanking market?

Answer: The global biobanking market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the biobanking market?

Answer: The major drivers for this market are significant capital allocation to the research and development of cutting-edge therapies, including regenerative medicine, personalized medicine and in-depth studies on cancer genomics and high incidence of cronic diseases.

Q4. What are the major segments for biobanking market?

Answer: The future of the biobanking market looks promising with opportunities in the therapeutics, drug discovery & clinical research, clinical diagnostics, and other markets.

Q5. Who are the key biobanking market companies?

Answer: Some of the key biobanking companies are as follows:

  • PHC Holdings
  • Becton
  • Dickinson and Company
  • Qiagen
  • Greiner Holding
  • Bay Biosciences
  • Bay Biosciences

Q6. Which biobanking market segment will be the largest in future?

Answer: Lucintel forecasts that equipment is expected to witness highest growth over the forecast period due to due to need of wide range of specialized equipments and products essential for the processing, analysis, storage, and transport of biological samples.

Q7. In biobanking market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to growing government efforts, including funding and the advancement of the biobanks market in the united states.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biobanking market by product & service (equipment, consumables, software, and services), sample type (blood, tissue, nucleic acids, and cell lines), application (therapeutics, drug discovery & clinical research, clinical diagnostics, and other applications), end use industry (pharmaceutical & biotechnology companies and cros, academic & research institutes, and hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biobanking Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biobanking Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biobanking Market by Product & Service
    • 3.3.1: Equipment
    • 3.3.2: Consumables
    • 3.3.3: Software
    • 3.3.4: Services
  • 3.4: Global Biobanking Market by Sample Type
    • 3.4.1: Blood
    • 3.4.2: Tissue
    • 3.4.3: Nucleic Acids
    • 3.4.4: Cell lines
  • 3.5: Global Biobanking Market by Application
    • 3.5.1: Therapeutics
    • 3.5.2: Drug Discovery & Clinical Research
    • 3.5.3: Clinical Diagnostics
    • 3.5.4: Other Applications
  • 3.6: Global Biobanking Market by End Use Industry
    • 3.6.1: Pharmaceutical & Biotechnology Companies and CROs
    • 3.6.2: Academic & Research Institutes
    • 3.6.3: Hospitals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biobanking Market by Region
  • 4.2: North American Biobanking Market
    • 4.2.2: North American Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications
  • 4.3: European Biobanking Market
    • 4.3.1: European Biobanking Market by Product & Service: Equipment, Consumables, Software, and Services
    • 4.3.2: European Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications
  • 4.4: APAC Biobanking Market
    • 4.4.1: APAC Biobanking Market by Product & Service: Equipment, Consumables, Software, and Services
    • 4.4.2: APAC Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications
  • 4.5: ROW Biobanking Market
    • 4.5.1: ROW Biobanking Market by Product & Service: Equipment, Consumables, Software, and Services
    • 4.5.2: ROW Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biobanking Market by Product & Service
    • 6.1.2: Growth Opportunities for the Global Biobanking Market by Sample Type
    • 6.1.3: Growth Opportunities for the Global Biobanking Market by Application
    • 6.1.4: Growth Opportunities for the Global Biobanking Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Biobanking Market by Region
  • 6.2: Emerging Trends in the Global Biobanking Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biobanking Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biobanking Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: PHC Holdings
  • 7.3: Becton
  • 7.4: Dickinson and Company
  • 7.5: QIAGEN
  • 7.6: Greiner Holding
  • 7.7: Bay Biosciences